Atossa Therapeutics
ATOS
ATOS
51 hedge funds and large institutions have $9.49M invested in Atossa Therapeutics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less capital invested
Capital invested by funds: $15.8M → $9.49M (-$6.36M)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
51
Holding in Top 10
–
Calls
$925K
Puts
$132K
Top Buyers
| 1 | +$105K | |
| 2 | +$60.8K | |
| 3 | +$51K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$23.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$21.1K |
Top Sellers
| 1 | -$264K | |
| 2 | -$155K | |
| 3 | -$132K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$110K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$76K |